Home > Boards > US OTC > Biotechs > Titan Pharmaceuticals Inc. (TTNP)

Big wall chopped at .289. Go time.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
INTL Member Profile
 
Followed By 45
Posts 3,171
Boards Moderated 0
Alias Born 01/07/14
160x600 placeholder
Titan Pharmaceuticals Reports Fourth Quarter And Full Year 2019 Financial Results PR Newswire (US) - 3/30/2020 4:03:00 PM
Titan Pharmaceuticals To Report Fourth Quarter And Full Year 2019 Financial Results On March 30, 2020 PR Newswire (US) - 3/26/2020 8:00:00 AM
Titan Pharmaceuticals Receives $5.9 Million From Exercise Of Warrants PR Newswire (US) - 3/5/2020 9:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 1/31/2020 4:36:42 PM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 1/31/2020 4:32:16 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/27/2020 11:34:23 AM
Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a) Edgar (US Regulatory) - 1/22/2020 9:12:25 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/16/2020 5:21:54 PM
Amended Statement of Ownership (sc 13g/a) Edgar (US Regulatory) - 1/13/2020 3:15:40 PM
Titan Pharmaceuticals Announces Addition Of Probuphine® To Federal Supply Schedule PR Newswire (US) - 1/13/2020 8:00:00 AM
Small Company Offering and Sale of Securities Without Registration (d) Edgar (US Regulatory) - 1/9/2020 4:24:50 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/7/2020 5:32:20 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 1/7/2020 5:19:20 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 1/7/2020 4:27:35 PM
Titan Pharmaceuticals Announces Pricing of $2.2 Million Registered Direct Offering PR Newswire (US) - 1/7/2020 9:15:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 12/31/2019 6:04:18 AM
Titan Pharmaceuticals Appoints Dr. Kate DeVarney To Its Board Of Directors PR Newswire (US) - 12/30/2019 8:00:00 AM
Additional Proxy Soliciting Materials (definitive) (defa14a) Edgar (US Regulatory) - 12/23/2019 1:38:34 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/20/2019 5:14:55 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 12/10/2019 2:31:38 PM
Titan Pharmaceuticals To Present At The First Annual BioTuesdays Pre-JPM Virtual Conference PR Newswire (US) - 12/3/2019 9:00:00 AM
Proxy Statement (definitive) (def 14a) Edgar (US Regulatory) - 11/20/2019 6:03:26 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 11/14/2019 4:11:06 PM
Titan Pharmaceuticals Reports Third Quarter 2019 Financial Results PR Newswire (US) - 11/14/2019 4:03:00 PM
Titan Pharmaceuticals To Release Third Quarter 2019 Financial Results On November 14 - Conference Call To Follow PR Newswire (US) - 11/7/2019 4:30:00 PM
INTL   Thursday, 01/16/20 06:13:35 PM
Re: None
Post # of 15963 
Big wall chopped at .289. Go time.

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist